1
Nevi were studied in order to assess the effects on benign melanocytes.
2
It was not found on non-metastatic melanomas or benign melanocytes.
3
The increase in p53 and bcl-2 raises the possibility that vaccination with melanocytic antigens stimulates a response in benign melanocytes.